•
Jun 30, 2024

Allovir Q2 2024 Earnings Report

Total Revenue
$0
EPS
-$0.05
Previous year: -$0.48
-89.6%
Gross Profit
$0
Cash and Equivalents
$130M
Previous year: $247M
-47.4%
Free Cash Flow
-$11.3M
Total Assets
$131M
Previous year: $283M
-53.7%

Allovir

Allovir